Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rakez Kayed

Showing results (11-20 of 201) with videos related to

Pageof 21
Sort By:
ACS Chemical Neuroscience|January 30, 2018
Azure C Targets and Modulates Toxic Tau OligomersFilippa Lo Cascio, Rakez Kayed
The Journal of Biological Chemistry|August 3, 2023
Flanking regions, amyloid cores, and polymorphism: the potential interplay underlying structural diversityAnukool A Bhopatkar, Rakez Kayed
Neurology|January 25, 2006
Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesisCharles G Glabe, Rakez Kayed
Journal of Alzheimer'S Disease : JAD|April 26, 2012
Molecular mechanisms of amyloid oligomers toxicityRakez Kayed, Cristian A Lasagna-Reeves
FEBS Letters|August 30, 2011
Astrocytes contain amyloid-β annular protofibrils in Alzheimer's disease brainsCristian A Lasagna-Reeves, Rakez Kayed
Journal of Neurochemistry|March 25, 2025
The Role of Glial Cell Senescence in Alzheimer's DiseaseFadhl Alshaebi, Alessia Sciortino, Rakez Kayed
Alzheimer'S & Dementia (New York, N. Y.)|March 22, 2018
Elevated phospholipase D isoform 1 in Alzheimer's disease patients' hippocampus: Relevance to synaptic dysfunction and memory deficitsBalaji Krishnan, Rakez Kayed, Giulio Taglialatela
NPJ Vaccines|March 7, 2018
Prospects for strain-specific immunotherapy in Alzheimer's disease and tauopathiesAlice Bittar, Urmi Sengupta, Rakez Kayed
Neurobiology of Disease|December 17, 2019
Advances and considerations in AD tau-targeted immunotherapyAlice Bittar, Nemil Bhatt, Rakez Kayed
Proteins|August 2, 2023
Protein aggregation and neurodegenerative disease: Structural outlook for the novel therapeuticsSharif Arar, Md Anzarul Haque, Rakez Kayed
Pageof 21

Showing results (11-20 of 201) with videos related to

Sort By:
Pageof 21
ACS Chemical Neuroscience|January 30, 2018
Azure C Targets and Modulates Toxic Tau OligomersFilippa Lo Cascio, Rakez Kayed
The Journal of Biological Chemistry|August 3, 2023
Flanking regions, amyloid cores, and polymorphism: the potential interplay underlying structural diversityAnukool A Bhopatkar, Rakez Kayed
Neurology|January 25, 2006
Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesisCharles G Glabe, Rakez Kayed
Journal of Alzheimer'S Disease : JAD|April 26, 2012
Molecular mechanisms of amyloid oligomers toxicityRakez Kayed, Cristian A Lasagna-Reeves
FEBS Letters|August 30, 2011
Astrocytes contain amyloid-β annular protofibrils in Alzheimer's disease brainsCristian A Lasagna-Reeves, Rakez Kayed
Journal of Neurochemistry|March 25, 2025
The Role of Glial Cell Senescence in Alzheimer's DiseaseFadhl Alshaebi, Alessia Sciortino, Rakez Kayed
Alzheimer'S & Dementia (New York, N. Y.)|March 22, 2018
Elevated phospholipase D isoform 1 in Alzheimer's disease patients' hippocampus: Relevance to synaptic dysfunction and memory deficitsBalaji Krishnan, Rakez Kayed, Giulio Taglialatela
NPJ Vaccines|March 7, 2018
Prospects for strain-specific immunotherapy in Alzheimer's disease and tauopathiesAlice Bittar, Urmi Sengupta, Rakez Kayed
Neurobiology of Disease|December 17, 2019
Advances and considerations in AD tau-targeted immunotherapyAlice Bittar, Nemil Bhatt, Rakez Kayed
Proteins|August 2, 2023
Protein aggregation and neurodegenerative disease: Structural outlook for the novel therapeuticsSharif Arar, Md Anzarul Haque, Rakez Kayed
Pageof 21